Lowering β-amyloid levels rescues learning and memory in a down syndrome mouse model

William J. Netzer, Craig Powell, Yi Nong, Jacqueline Blundell, Lili Wong, Karen Duff, Marc Flajolet, Paul Greengard

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Abstract

β-amyloid levels are elevated in Down syndrome (DS) patients throughout life and are believed to cause Alzheimer's disease (AD) in adult members of this population. However, it is not known if β-amyloid contributes to intellectual disability in younger individuals. We used a γ-secretase inhibitor to lower β-amyloid levels in young mice that model DS. This treatment corrected learning deficits characteristic of these mice, suggesting that β-amyloid-lowering therapies might improve cognitive function in young DS patients.

Original languageEnglish (US)
Article numbere10943
JournalPloS one
Volume5
Issue number6
DOIs
StatePublished - 2010

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Lowering β-amyloid levels rescues learning and memory in a down syndrome mouse model'. Together they form a unique fingerprint.

Cite this